Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.

× No keyword cloud information.

26 in total

Review 1. Prolonged QTc interval in cancer therapeutic drug development: defining arrhythmic risk in malignancy.

Authors: Joanna M Brell
Journal: Prog Cardiovasc Dis Date: 2010 Sep-Oct Impact factor: 8.194

Review 2. Cardiac KATP channels in health and disease.

Authors: Garvan C Kane; Xiao-Ke Liu; Satsuki Yamada; Timothy M Olson; Andre Terzic
Journal: J Mol Cell Cardiol Date: 2005-04-25 Impact factor: 5.000

Review 3. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors: Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal: Nat Rev Drug Discov Date: 2007-11 Impact factor: 84.694

Review 4. Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated?

Authors: Norman Stockbridge; Joel Morganroth; Rashmi R Shah; Christine Garnett
Journal: Drug Saf Date: 2013-03 Impact factor: 5.606

5. Is prolonged QTc sufficient to predict survival in patients with intracerebral hemorrhage?

Authors: Clara Hjalmarsson; Lennart Bergfeldt
Journal: Ann Noninvasive Electrocardiol Date: 2014-02-19 Impact factor: 1.468

Review 6. Genetics of acquired long QT syndrome.

Authors: Dan M Roden; Prakash C Viswanathan
Journal: J Clin Invest Date: 2005-08 Impact factor: 14.808

7. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.

Authors: Dawood Darbar; John Kimbrough; Asif Jawaid; Robert McCray; Marylyn D Ritchie; Dan M Roden
Journal: J Am Coll Cardiol Date: 2008-02-26 Impact factor: 24.094

Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.